BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14949094)

  • 1. Comparative effectiveness of five newly synthesized arsenical compounds in treatment of leukemia in mice.
    ENGLE RL; REZNIKOFF P; LOTT WA; YALE HL
    Proc Soc Exp Biol Med; 1952 Jul; 80(3):489-92. PubMed ID: 14949094
    [No Abstract]   [Full Text] [Related]  

  • 2. 1,3-Benzodioxole Derivatives Improve the Anti-Tumor Efficiency of Arsenicals.
    Shi XM; She WY; Liu TT; Gao LX; Liu YJ; Liu Y
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenical chemotherapeutic drugs. XV. Studies on arsenical compounds as anthelmintics.
    UEDA T; TSUJI T
    Pharm Bull; 1954 Mar; 2(1):19-22. PubMed ID: 13177111
    [No Abstract]   [Full Text] [Related]  

  • 4. Arsenical chemotherapeutic drugs. XIV. Studies on the mode of antibacterial action of organic arsenical compounds.
    TOYOSHIMA S; KANO S; UEDA T
    Pharm Bull; 1954 Mar; 2(1):16-9. PubMed ID: 13177110
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis, chemistry, and preliminary pharmacology of arsenical nitrogen mustards and structurally related nonalkylating arsenicals.
    Bardos TJ; Datta-Gupta N; Hebborn P
    J Med Chem; 1966 Mar; 9(2):221-7. PubMed ID: 5911802
    [No Abstract]   [Full Text] [Related]  

  • 6. Arsenic trioxide (As₂O₃) inhibits murine WEHI-3 leukemia in BALB/c mice in vivo.
    Lai TY; Lin JJ; Huang WW; Kuo SC; Wen YF; Lai IC; Lin CC; Yang JS; Chung JG
    Environ Toxicol; 2012 May; 27(6):364-71. PubMed ID: 20886602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential sensitivity of Trypanosoma brucei rhodesiense isolates to in vitro lysis by arsenicals.
    Yarlett N; Goldberg B; Nathan HC; Garofalo J; Bacchi CJ
    Exp Parasitol; 1991 Feb; 72(2):205-15. PubMed ID: 1849084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanocidal activity of a new series of arsenical compounds the spiroarsorans.
    Loiseau P; Bories C; Gayral P; Wolf JG
    Farmaco Sci; 1988; 43(7-8):657-63. PubMed ID: 3224710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of urethane, X-rays, potassium arsenite, benzol, on survival time in transplanted mouse leukemia.
    KIRSCHBAUM A; JUDD T
    Proc Soc Exp Biol Med; 1948 Jun; 68(2):377-80. PubMed ID: 18869353
    [No Abstract]   [Full Text] [Related]  

  • 10. The lesions produced in the central nervous system by certain organic arsenical compounds.
    HURST EW
    J Pathol Bacteriol; 1959 Apr; 77(2):523-34. PubMed ID: 13642199
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of arsenical drugs on glutathione metabolism of Litomosoides carinii.
    Bhargava KK; Le Trang N; Cerami A; Eaton JW
    Mol Biochem Parasitol; 1983 Sep; 9(1):29-35. PubMed ID: 6669159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antifilarial activity of a novel group of organic arsenicals upon Brugia pahangi.
    Denham DA; Oxenham SL; Midwinter I; Friedheim EA
    J Helminthol; 1986 Sep; 60(3):169-72. PubMed ID: 3745871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the development of arsenical resistance in trypanosomes in vitro.
    Hawking F; Walker PJ
    Exp Parasitol; 1966 Feb; 18(1):63-86. PubMed ID: 5909674
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in properties of adenosine transporters in Trypanosoma evansi and modes of selection of resistance to the melaminophenyl arsenical drug, Mel Cy.
    Suswam EA; Taylor DW; Ross CA; Martin RJ
    Vet Parasitol; 2001 Dec; 102(3):193-208. PubMed ID: 11777599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenical chemotherapeutic drugs. XVII. Resistance development and cross-resistance of Shigella dysenteriae to 3-nitro-4-hydroxyphenyl-bis (alpha, beta-dicarboxyethyl) dithioarsenite and 3-amino-4-hydroxydiphenyl- (alpha, beta-dicarboxyethyl)-thioarsinite.
    KANO S; TOYOSHIMA S
    Pharm Bull; 1954 Dec; 2(4):305-7. PubMed ID: 14356868
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mechanism of arsenic compound resistance in prokaryotes and eukaryotes].
    Wysocki R; Bobrowicz P; Ułaszewski S
    Postepy Biochem; 1999; 45(4):304-12. PubMed ID: 10786374
    [No Abstract]   [Full Text] [Related]  

  • 17. A mitochondria-targeted organic arsenical accelerates mitochondrial metabolic disorder and function injury.
    Fan XY; Liu YJ; Cai YM; Wang AD; Xia YZ; Hu YJ; Jiang FL; Liu Y
    Bioorg Med Chem; 2019 Mar; 27(5):760-768. PubMed ID: 30665675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of organic arsenic compounds on tissue enzymes and proteins and on tissue metabolism.
    GORDON JJ; QUASTEL JH
    Nature; 1947 Jan; 159(4029):97. PubMed ID: 20281231
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cellular respiration in the presence of arsenical substances].
    CUVELIER R; TRONCHE P; LAROUSSINIE C; ANDRAUD G
    C R Seances Soc Biol Fil; 1961; 155():763-6. PubMed ID: 13882836
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversal effect of arsenic sensitivity in human leukemia cell line K562 and K562/ADM using realgar transforming solution.
    Wang X; Zhang X; Xu Z; Wang Z; Yue X; Li H
    Biol Pharm Bull; 2013; 36(4):641-8. PubMed ID: 23358330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.